首页|吡格列酮介入18F-FDG PET/CT多时相显像对孤立性肺结节的鉴别诊断

吡格列酮介入18F-FDG PET/CT多时相显像对孤立性肺结节的鉴别诊断

扫码查看
目的 评价吡格列酮(PIO)介入后,18F-FDG PET/CT多时相显像对孤立性肺结节(SPN)的鉴别诊断价值。方法 收集东莞东华医院核医学科2020年10月~2023年1月共86例SPN患者,对其行18F-FDG PET/CT多时相(1h、2h、4 h)显像,PIO介入后显像的42例为实验组(PIO组),常规显像的44例为对照组(非PIO组),分别测量各结节最大标准化摄取值(SUVmax1、SUVmax2、SUVmax4),计算2h、4h延迟显像滞留指数(RI2、RI4),结合病理及随访,分析实验组是否提高对SPN良恶性鉴别诊断效能,采用Mann-Whitney U检验及ROC曲线分析数据。结果 各组SUVmax2、SUVmax4分别与SUVmax1比较,差异均有统计学意义(P<0。001)。PIO组内恶性SPN的SUVmax1、SUVmax2、SUVmax4、RI4均高于良性SPN,差异有统计学意义(P<0。05),RI2间的差异无统计学意义(P=0。214)。非PIO组内恶性与良性SPN各值差异均无统计学意义(P>0。05)。两组恶性病变的RI4差异有统计学意义(P=0。034),其余各值差异均无统计学意义(P>0。05)。两组良性病变以上各值的差异均无统计学意义(P>0。05)。以RI>10%为恶性病变的诊断标准,PIO组诊断SPN为恶性病变的准确性、灵敏度、特异度、阳性预测值、阴性预测值均高于非PIO组,4h各指标均高于2 h。ROC曲线显示,PIO组RI4诊断恶性SPN的曲线下面积为0。732,明显高于其他各组。结论 SPN经PIO作用后,4 h 18F-FDG PET/CT延迟显像可一定程度提高恶性肺结节的诊断效能。
Differential diagnostic value of 18F-FDG PET/CT multi-phase imaging with pioglitazone intervention in solitary pulmonary nodules
Objective To evaluate the differential diagnostic value of 18F-FDG PET/CT multi-phase imaging after treated with pioglitazone(PIO)in the diagnosis of solitary pulmonary nodules(SPN).Methods Eighty-six SPN patients in the Department of Nuclear Medicine of Dongguan Tungwah hospital from October 2020 to January 2023 were collected.All patients were performed 18F-FDG PET/CT multi-phase(1 h,2 h,4 h)imaging,and 42 cases of imaging after PIO treatment were in the experimental group(PIO group),while 44 cases of conventional imaging were in the control group(Non-PIO group).The maximum standardized uptake values(SUVmax1,SUVmax2,SUVmax4)of each SPN was measured separately,and the retention index(RI2,RI4)of 2 h and 4 h delayed imaging was calculated.Finally,based on pathology and follow-up,whether the experimental group has improved the diagnostic efficacy in distinguishing between benign and malignant SPN was analyzed.The data was analyzed by using Mann-Whitney U test and ROC curve.Results There were statistically significant differences between SUVmax2 and SUVmax4 in each group compared to SUVmax1(P<0.001).The SUVmax1,SUVmax2,SUVmax4 and RI4 of malignant SPN in the PIO group were significantly higher than those of benign SPN(P<0.05),while there was no statistical significance between RI2(P=0.214).There was no statistically significant difference in SPN values between malignant and benign SPN within the Non-PIO group(P>0.05).There was a statistically significant difference in RI4 between the two groups of malignant lesions(P=0.034),while there was no statistically significant difference in the other values(P>0.05).There was no statistically significant difference between the above values of benign lesions between the two groups(P>0.05).Using RI>10%as the diagnostic criterion for malignant lesions,the accuracy,sensitivity,specificity,positive predictive value,and negative predictive value of diagnosing malignant SPN in the PIO group were higher than those in the Non-PIO group,and all indicators in the 4 h were higher than those in the 2 h.ROC curves showed that the area under the curve of the PIO group RI4 in diagnosing malignant SPN was 0.732,significantly higher than other groups.Conclusion After PIO treatment,the 4 h 18F-FDG PET/CT delayed imaging of SPN can improve the diagnostic efficacy of malignant pulmonary nodules to a certain extent.

pioglitazonepositron emission tomography imagingsolitary pulmonary nodulemulti-phase imagingfluorodeoxyglucose

贾志斌、高中山、曾祥高、吴竟雄、李扬彬、苏晓燕、魏帮建、黄威、陈昌伟

展开 >

东莞东华医院核医学科,广东 东莞 523110

东莞东华医院呼吸与危重症医学科,广东 东莞 523110

东莞东华医院放射科,广东 东莞 523110

东莞东华医院肾病科,广东 东莞 523110

东莞东华医院病理科,广东 东莞 523110

展开 >

吡格列酮 正电子发射断层显像 孤立性肺结节 多时相 氟代脱氧葡萄糖

东莞市社会发展科技(一般)项目

20211800901252

2024

分子影像学杂志
南方医科大学

分子影像学杂志

CSTPCD
ISSN:1674-4500
年,卷(期):2024.47(8)